NOVONESIS

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NOVONESIS and other ETFs, options, and stocks.

About NVZMY

Novonesis (Novozymes A/S) engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. 

CEO
Ester Baiget
CEOEster Baiget
Employees
11,641
Employees11,641
Headquarters
Lyngby, North Denmark
HeadquartersLyngby, North Denmark
Founded
Founded
Employees
11,641
Employees11,641

NVZMY Key Statistics

Market cap
28.11B
Market cap28.11B
Price-Earnings ratio
42.97
Price-Earnings ratio42.97
Dividend yield
0.98%
Dividend yield0.98%
Average volume
92.71K
Average volume92.71K
High today
$60.62
High today$60.62
Low today
$59.78
Low today$59.78
Open price
$60.22
Open price$60.22
Volume
28.01K
Volume28.01K
52 Week high
$75.99
52 Week high$75.99
52 Week low
$49.90
52 Week low$49.90

NVZMY News

TipRanks 6d
Novonesis price target lowered to DKK 500 from DKK 540 at JPMorgan

JPMorgan lowered the firm’s price target on Novonesis (NVZMY) to DKK 500 from DKK 540 and keeps an Overweight rating on the shares. Unlock hedge fund-level dat...

Analyst ratings

74%

of 19 ratings
Buy
73.7%
Hold
21.1%
Sell
5.3%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.